News | PROXIDRUGS

PROXIDRUGS takes part in the ClusterTalk of the Technologieland Hessen

You would like to learn - which objectives the Hessian clusters and networks pursue? - what activities there are in the...

ProxiDETECT partner Revvity launches new kit

The associated PROXIDRUGS partner Revvity launched a detection kit for quantifying the expression level of RNA-binding motif protein 39...

PROXIDRUGS Workshop on conceptualization of the 2nd funding period

Today the PROXIDRUGS consortium met to get started with the conceptualization of the second funding period. It was a fruitful day full of...

New partners welcome – strategic expansion of PROXIDRUGS cluster in next funding round

Join a continuously expanding research-driven partnership focused on innovative therapies for human diseases. Funded within the first...

Jochen Hückmann Foundation Guest Professorship for Judith Frydman

The PROXIDRUGS community welcomes Judith Frydman (Stanford University, USA) at Goethe University. Judith Frydman was awarded with the...

Launch of Revvity – a PROXIDRUGS partner

Revvity, Inc., a science-based solutions company that leverages innovation across life sciences and diagnostics to help improve lives...

Ivan Đikić receives Louis-Jeantet Prize for Medicine

Together with Brenda Schulman, Director at the Max Planck Institute of Biochemistry in Martinsried, PROXIDRUGS speaker Ivan Đikić will...

PROXIDRUGS project leaders Ivan Đikić and Stefan Knapp are Highly Cited Researchers 2022

The list of Highly Cited Researchers identifies pioneers in their respective fields who repeatedly demonstrated significant and broad...

Commentary: Localization matters!

In the latest issue of Cell Chemical Biology, PROXIDRUGS scientists Varun Shah and Ivan Đikić comment on an article published by Simpson...

Successful PROXIDRUGS annual meeting

On October 17th and 18th, the second annual PROXIDRUGS meeting took place in Bad Brückenau. Exciting research results were presented, and...